Literature DB >> 8454084

Aortofemoral bypass in the presence of total juxtarenal aortic occlusion.

T E Madiba1, J V Robbs.   

Abstract

Forty-two patients with total juxtarenal aortic occlusion were offered aortobifemoral bypass over a 6 year period. The majority presented with claudication and males predominated. In all patients, aortobifemoral bypass was successfully performed. The groins were initially explored and the aorta was then thrombectomised prior to the standard aortobifemoral bypass. Follow-up period ranged between 6 months and 5 years. There was a 4.8% perioperative mortality. Graft occlusion occurred in two patients in the immediate postoperative period, resulting in major amputation in one patient. Three patients developed graft occlusion during the period of follow-up, none of whom required amputation. Graft sepsis occurred in one patient and one patient developed a false aneurysm. We conclude that angiography cannot predict the feasibility of bypass in the presence of total aortic occlusion, and in our hands aortobifemoral bypass is feasible in all these patients. Early results are no different from the rest of the patients with aortoiliac disease.

Entities:  

Mesh:

Year:  1993        PMID: 8454084     DOI: 10.1016/s0950-821x(05)80548-1

Source DB:  PubMed          Journal:  Eur J Vasc Surg        ISSN: 0950-821X


  3 in total

1.  Primary patency and amputation free survival after endovascular management of infrarenal aorta total occlusions.

Authors:  Ender Özgün Çakmak; Münevver Sarı; Zeki Şimşek; Şeyhmus Külahçıoğlu; Ali Karagöz; Çetin Geçmen; Çağrı Kafkas; İbrahim Akın İzgi; Cevat Kırma
Journal:  Anatol J Cardiol       Date:  2021-04       Impact factor: 1.596

2.  Experiences of Surgical Treatment for Juxtarenal Aortic Occlusion.

Authors:  Hee Jae Jun
Journal:  Vasc Specialist Int       Date:  2014-03-30

3.  Revascularization of Chronic Total Occlusion of the Infrarenal Aorta in a Patient with Triple Vessel Disease: Report of a Case Treated by Endovascular Approach.

Authors:  Mahek Shah; Soumya Patnaik; Rahul Sinha; Issac Opoku-Asare; Khalid Chaudhry; Sean Janzer
Journal:  Case Rep Cardiol       Date:  2017-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.